Search 
Saturday, February 04, 2012 ..:: Protocols » CTN Protocol ::.. Register  Login
 Clinical Trials Network Protocol Listing Minimize

Below is a listing of protocols available to Network members. CTN members may request any of the protocols below by completing a study request form. Some protocols may already have active CTN members participating in the study. All participating centers are posted in the right column.

For CTN members or other institutions with an active confidentiality disclosure agreement in place, you may see a table below for protocols in development that are available to investigators to assess their interest in the trial. If you do not see this table, you may contact the Network office to request access.

All Protocol documents are available for viewing by clicking on the protocol hyperlinks. If you are a CTN Member listed on your institution's Delegation of Authority or a multicenter authorized user, you will have access to the the full protocol documents.  If wish to gain access to particular trial, please contact the Network office at hcc-ctn@musc.edu or 843-792-1753. Thank you!


 Print   
 Protocols Available for CTN Activation and Enrollment Minimize

last updated August 11, 2011

Disease Site

CTO

Protocol Title

Participating Centers

GU
100892
 
A Phase II Study of Neoadjuvant Cisplatin, Gemcitabine, and Bevacizumab Followed by Radical Cystectomy for Patients with Muscle Invasive Resectable Non-Metastatic Transitional Cell Carcinoma (TCC) of the Bladder
Hollings Cancer Center
HN
100949
Multicenter Randomized Phase II Study of Erlotinib Cisplatin and Radiotherapy versus Cisplatin and Radiotherapy in Patients with Stage III and IV Squamous Cell Carcinoma of the Head and Neck
Hollings Cancer Center
McLeod Regional Medical Center
Spartanburg Regional Healthcare System
(closed to accrual)
GI
101282
A Randomized Open-Label Multi-Institution Phase II Study of the Combination of Bevacizimab and Erlotinib Compared to Sorafenib in the First-Line Treatment of Patients with Advanced Hepatocellular Carcinoma
Hollings Cancer Center
University of Southern California
Tennessee Oncology
Wake Forest University
University of Virginia

Columbia University Medical Center

California Pacific Medical Center

Malignant
Hematology
 
101376

 

 
A Phase II Trial of Intracycle Sequential Ofatumumab and Lenalidomide for the Treatment of Chronic Lymphocytic Leukemia in Patients Previously Exposed to Rituximab
Hollings Cancer Center
Thoracic
101466
 
A Phase I Trial of Preoperative Carboplatin or Cisplatin and Pemetrexed with Thoracic Radiation Therapy Followed by Lobectomy in Resectable Stage III Patients with Non-Squamous Non Small Cell Lung Cancer (NSCLC)
Hollings Cancer Center
Thoracic
101440
NavIGATE: Navigation to Increase Guidance and Awareness of Trials for Thoracic and Esophageal Cancers
Hollings Cancer Center
Spartanburg Regional Medical Center

St. Joseph's Candler  

(closed to accrual) 

GI
101504
APOGEE ABC-101: A Phase I, Open-Label, Dose-Escalation, Safety, Pharmacokinetic and Pharmocodynamic Study of ABC294640 in Patients with Advanced Solid Tumors
Hollings Cancer Center
Thoracic
101596
The ATTAIN Lung Study: A Therapeutic Trial of Afatinib in the Neoadjuvant Setting
Molecular Effects of Afatinib: A Window of Opportunity Trial in Early Stage NSCLC
Hollings Cancer Center

 

 

 


 Print   
 Protocols Closed to Enrollment Minimize

 Print   
 CTN Studies and Reference Numbers Minimize

 Print   
 CTN Studies Newsletters Minimize

CollectionsCollections CategoriesCategories SearchSearch 

  Search Document Exchange

 




Search 


 Print   
Copyright 2008 by Hollings Cancer Center   Terms Of Use  Privacy Statement